Delmitide

Product Name: Delmitide

CAS No: 287096-87-1

Purity: 95%

Molar Mass: 1228.6

Chemical Formula: C59H105N17O11

Synonyms: RDP58

Storage: Store at -20 degrees Celsius

Sequence: RXXXRXXXGY

Application:

Delmitide is a synthetic peptide known for its immunomodulatory properties, specifically designed to enhance the body's immune response. It works by activating macrophages and stimulating the production of cytokines, which play a crucial role in orchestrating the immune response against infections and malignancies. Delmitide has shown promise in preclinical studies for boosting immune function, making it a potential therapeutic agent for cancer immunotherapy, chronic infections, and immune deficiency disorders. Its ability to modulate immune activity offers a novel approach for enhancing the effectiveness of existing treatments and improving patient outcomes in various immunological conditions.

Current Research:

Delmitide, a synthetic peptide with immunomodulatory properties, has emerged as a potential candidate in drug discovery for its unique mechanisms and broad therapeutic applicability. Structurally designed to mimic specific bioactive domains, delmitide exhibits high stability and targeted activity, making it suitable for diverse research and clinical applications.

Recent studies highlight delmitide's ability to modulate immune responses, particularly in regulating pro-inflammatory cytokines. This has positioned it as a promising agent for the treatment of chronic inflammatory diseases and autoimmune disorders. Its immunomodulatory effects are mediated through specific receptor-ligand interactions that attenuate hyperactive immune responses while preserving essential defense mechanisms.

Delmitide’s potential extends into oncology, where it has shown promise in modulating the tumor microenvironment. By influencing immune cell infiltration and cytokine profiles, delmitide may enhance the efficacy of existing immunotherapies, including immune checkpoint inhibitors. Additionally, preclinical research suggests delmitide's potential in promoting tissue repair and regeneration, particularly in conditions characterized by chronic inflammation or tissue damage.

One of delmitide’s advantages lies in its favorable pharmacokinetics, including high stability, low immunogenicity, and compatibility with various delivery methods. These properties make it a versatile tool for therapeutic development and experimental applications.

Ongoing research is focused on optimizing delmitide’s efficacy through formulation innovations and combination therapies. Its integration into nanocarrier systems and other advanced delivery platforms is expected to enhance bioavailability and tissue targeting, further expanding its therapeutic scope.

For drug discovery researchers, delmitide represents an exciting frontier in peptide-based therapeutics. Its multifaceted activity profile, combined with its stability and specificity, underscores its potential in addressing complex conditions, from immune-mediated diseases to cancer and regenerative medicine.

Reference:

Cardoso, M. H., Cândido, E. S., Oshiro, K. G., Rezende, S. B., & Franco, O. L. (2018). Peptides containing d-amino acids and retro-inverso peptides: general applications and special focus on antimicrobial peptides. In Peptide Applications in Biomedicine, Biotechnology and Bioengineering (pp. 131-155). Woodhead Publishing.